[{"id":"45e3461c-56e3-4444-b7b0-4f25c92bd42c","acronym":"","url":"https://clinicaltrials.gov/study/NCT01935154","created_at":"2021-01-18T08:45:09.365Z","updated_at":"2024-07-02T16:36:58.773Z","phase":"Phase 2","brief_title":"Efficacy Study of Vx001 Vaccine in NSCLC Patients","source_id_and_acronym":"NCT01935154","lead_sponsor":"Vaxon Biotech","biomarkers":" TERT","pipe":"","alterations":" ","tags":["TERT"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Vx-001"],"overall_status":"Completed","enrollment":" Enrollment 221","initiation":"Initiation: 08/01/2012","start_date":" 08/01/2012","primary_txt":" Primary completion: 01/01/2017","primary_completion_date":" 01/01/2017","study_txt":" Completion: 01/01/2017","study_completion_date":" 01/01/2017","last_update_posted":"2019-06-19"}]